Sylvia Nikkho

11PUBLICATIONS
38CO-AUTHORS
Cancer diagnosisRespiratory diseasesInfant and child healthHealth promotionAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 11, 2026
Pathogenesis and Phenotypes of Pulmonary Vascular Disease in COPD: A Consensus Statement From the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative - PH Group 3 Workstream.

|Aug 20, 2025
Significance of Pulmonary Vascular Dysfunction in Chronic Obstructive Pulmonary Disease.

Steven D Nathan, Lucilla Piccari, Steven H Abman

|Jul 17, 2025
Enhancing Drug Development for Paediatric Pulmonary Hypertension-An Integrative Perspective.

Steven H Abman, Sylvia M Nikkho, Rolf M F Berger

|Dec 11, 2024
Screening and diagnosis of pulmonary hypertension associated with chronic lung disease (PH-CLD): A consensus statement from the pulmonary vascular research institute's innovative drug development initiative-group 3 pulmonary hypertension.

P Vitulo, L Piccari, S J Wort

|Jan 11, 2024
Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension.

Oksana A Shlobin, Eric Shen, Stephen J Wort

|Dec 25, 2023
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group.

Kellie Morland, Christian Gerges, Jean Elwing

Pageof 2

Frequent Collaborators

7 joint publications

Steven D Nathan

6 joint publications

Lucilla Piccari

4 joint publications

Stephen John Wort

4 joint publications

Oksana A Shlobin